WHO ICTRP trial
Effect of drug intervention on hypertensive patients
CTRI/2019/11/021961 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2019/11/021961 |
|---|---|
| Public title | Effect of drug intervention on hypertensive patients |
| Scientific title | Comparison of efficacy and safety of azilsartan and amlodipine versus telmisartan and amlodipine in hypertensive patients-A non-inferiority study |
| Primary sponsor | All India Institute of medical Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: I10- Essential (primary) hypertension |
| Interventions | Intervention1: Azilsartan 40mg and amlodipine 5mg daily for 12 weeks in the morning: Azilsartan 40mg and amlodipine 5mg daily for 12 weeks in the morning Control Intervention1: Telmisartan 40 mg and Amlodipine 5 mg: Telmisartan 40 mg and… |
| Registration date | Nov 11, 2019 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: